239 related articles for article (PubMed ID: 11159836)
21. Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors.
Lin KH; Shieh HY; Hsu HC
Endocrinology; 2000 Jul; 141(7):2540-7. PubMed ID: 10875256
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.
Lim HJ; Moon I; Han K
Endocrinology; 2004 Jun; 145(6):2886-95. PubMed ID: 15001550
[TBL] [Abstract][Full Text] [Related]
23. Nuclear corepressors enhance the dominant negative activity of mutant receptors that cause resistance to thyroid hormone.
Tagami T; Jameson JL
Endocrinology; 1998 Feb; 139(2):640-50. PubMed ID: 9449636
[TBL] [Abstract][Full Text] [Related]
24. The interaction of TRbeta1-N terminus with steroid receptor coactivator-1 (SRC-1) serves a full transcriptional activation function of SRC-1.
Iwasaki T; Takeshita A; Miyazaki W; Chin WW; Koibuchi N
Endocrinology; 2006 Mar; 147(3):1452-7. PubMed ID: 16357047
[TBL] [Abstract][Full Text] [Related]
25. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
26. Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma.
Kamiya Y; Puzianowska-Kuznicka M; McPhie P; Nauman J; Cheng SY; Nauman A
Carcinogenesis; 2002 Jan; 23(1):25-33. PubMed ID: 11756220
[TBL] [Abstract][Full Text] [Related]
27. A method for efficient production of recombinant thyroid hormone receptors reveals that receptor homodimer-DNA binding is enhanced by the coactivator TIF2.
Diallo EM; Thompson DL; Koenig RJ
Protein Expr Purif; 2005 Apr; 40(2):292-8. PubMed ID: 15766871
[TBL] [Abstract][Full Text] [Related]
28. A novel mechanism of thyroid hormone-dependent negative regulation by thyroid hormone receptor, nuclear receptor corepressor (NCoR), and GAGA-binding factor on the rat cD44 promoter.
Kim SW; Ho SC; Hong SJ; Kim KM; So EC; Christoffolete M; Harney JW
J Biol Chem; 2005 Apr; 280(15):14545-55. PubMed ID: 15701601
[TBL] [Abstract][Full Text] [Related]
29. The nuclear corepressors recognize distinct nuclear receptor complexes.
Cohen RN; Putney A; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
[TBL] [Abstract][Full Text] [Related]
30. GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor.
Anafi M; Yang YF; Barlev NA; Govindan MV; Berger SL; Butt TR; Walfish PG
Mol Endocrinol; 2000 May; 14(5):718-32. PubMed ID: 10809234
[TBL] [Abstract][Full Text] [Related]
31. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
[TBL] [Abstract][Full Text] [Related]
32. The N-Terminal A/B domain of the thyroid hormone receptor-beta2 isoform influences ligand-dependent recruitment of coactivators to the ligand-binding domain.
Tian H; Mahajan MA; Wong CT; Habeos I; Samuels HH
Mol Endocrinol; 2006 Sep; 20(9):2036-51. PubMed ID: 16645037
[TBL] [Abstract][Full Text] [Related]
33. The gene regulating activity of thyroid hormone nuclear receptors is modulated by cell-type specific factors.
Lin K; Chen Sl; Zhu XG; Shieh H; McPhie P; Cheng S
Biochem Biophys Res Commun; 1997 Sep; 238(2):280-4. PubMed ID: 9299494
[TBL] [Abstract][Full Text] [Related]
34. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE
J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943
[TBL] [Abstract][Full Text] [Related]
35. The thyroid hormone receptor variant alpha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors.
Tagami T; Kopp P; Johnson W; Arseven OK; Jameson JL
Endocrinology; 1998 May; 139(5):2535-44. PubMed ID: 9564869
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 Tat binding protein-1 is a transcriptional coactivator specific for TR.
Ishizuka T; Satoh T; Monden T; Shibusawa N; Hashida T; Yamada M; Mori M
Mol Endocrinol; 2001 Aug; 15(8):1329-43. PubMed ID: 11463857
[TBL] [Abstract][Full Text] [Related]
37. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H
Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
[TBL] [Abstract][Full Text] [Related]
38. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
Cohen RN; Wondisford FE; Hollenberg AN
Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
[TBL] [Abstract][Full Text] [Related]
39. Tissue-specific differential repression of gene expression by a dominant negative mutant of thyroid hormone beta1 receptor.
Bhat MK; Dace A; Cheng SY
Thyroid; 1999 Apr; 9(4):411-8. PubMed ID: 10319950
[TBL] [Abstract][Full Text] [Related]
40. A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators.
Collingwood TN; Rajanayagam O; Adams M; Wagner R; Cavaillès V; Kalkhoven E; Matthews C; Nystrom E; Stenlof K; Lindstedt G; Tisell L; Fletterick RJ; Parker MG; Chatterjee VK
Proc Natl Acad Sci U S A; 1997 Jan; 94(1):248-53. PubMed ID: 8990194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
